Streeting Warns Against Unchecked Market Forces in Shaping PostIndustrial Economy
Coastal Erosion Threatens UK Infrastructure Assets Roads Homes and Railways at Risk
Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Acknowledges Regulatory Scrutiny
Retail Hiring Accelerates in April But Consumer Caution Signals Potential Headwinds
Quantum Computing Stocks Surge as US Government Unveils 2 Billion Funding and Equity Initiative
Japanese Snack Maker Behind Shiruko Sand Eyes Singapore and Southeast Asia for Expansion
MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue
FMC Q1 2026 Earnings EPS Surpasses Estimates with NarrowerThanExpected Loss
Landstar System LSTR Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher
ENPH Q1 2026 Earnings EPS Surprises to the Upside as Enphase Navigates Market Headwinds
VSCO Q1 2026 Earnings Earnings Surge Past Estimates Stock Reacts Positively
Moving iMage Technologies Inc MITQ Q1 2026 Earnings Net Loss Reported as Stock Edges Higher
Sequans Communications SQNS Gains 37 as Shares Test Key Technical Levels
Siebert Financial Corp SIEB Surges 319 as Bullish Momentum Builds Near Key Resistance
National Grid NGG Gains 124 as Utility Stocks Attract Defensive Flows
Insight Digital Partners II Units DYORU Hovers Near Support Amid Modest Decline
Nuveen Select Tax Free Income Portfolio NXP Holds Near Resistance Amid Modest Gains
Myanmars Political Transition CPJ Urges Press Freedom Benchmarks
SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss
Stardust Power Inc SDST Surges 68 as Bulls Regain 242 Support Level
ROKU Q1 2026 Earnings EPS Surges Past Estimates with 71 Beat
DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty
IESC Q1 2026 Earnings EPS Surges 35 Above Expectations Stock Rises
REZI Q1 2026 Earnings Solid Earnings Beat Amid Market Caution
VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
Heritage Insurance Holdings Inc HRTG Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment
C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue